Subscribe to Newsletter
Discovery & Development Formulation

Controlling Crystallization

Researchers working to gain greater knowledge into crystallization believe that functionalized glass can trigger nucleation of specific crystals.

Discovery & Development Packaging

Beyond Keeping Up Appearances

| Charlotte Miller

You have the perfect drug and the right packaging to protect it. All is well until the medication reaches the patient, who habitually pops the tablets into another container for easy storage or leaves them exposed to the atmosphere. Film coatings are more than just a pretty face.

Business & Regulation Business Practice

Making Small Biotech Work

| Bruno Speder

Innovation is increasingly coming from small biotechs, but such companies rely on external funding to develop the compounds. A solid regulatory strategy is essential to convince investors to fund the further development.

Discovery & Development Clinical Trials

More Trial, Less Error

| Sponsored by Catalent

The pressure for increased efficiency pervades the pharma industry, including the clinical trials sector, where traditional supply models can lead to overstocking, waste and higher costs. Is there a more effective supply strategy?

Business & Regulation Clinical Trials

Back to Biologics

| Christian Schneider

Sitting Down With... Christian Schneider, Director of the National Institute for Biological Standards and Control (NIBSC), UK.

Discovery & Development Analytical Science

The Search for the Ideal Detector

| Dorina Kotoni

Will aerosol-based detectors ever meet all the needs of the pharmaceutical industry?

Business & Regulation Standards & Regulation

Time to Limit Antibiotic Pollution

| Johan Bengtsson-Palme, D. G. Joakim Larsson

The use and misuse of antibiotics is a major driver behind the drug-resistance problem, but large environmental discharges of antibiotics from pharma manufacturing can also contribute. It’s time for companies to live up to their ethical responsibilities.

Manufacture Business Practice

What Price Glory?

| Ann Hayes

The pharmaceutical industry receives its fair share of both praise and scorn. Behind the politics, the hard work and impressive achievements of legions of industry researchers often go unnoticed.

Manufacture Small Molecules

Moving from Batch to Continuous

| James Strachan

The first switch from batch to continuous manufacturing has been made – and approved by the FDA. Will pharma’s future be continuous?

Discovery & Development Analytical Science

Affliction Prediction

| James Strachan

Could drug development be guided by a new algorithm that predicts the side effects of potential medicines?

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register